Stem cell transplant for COPD: a safety and early efficacy study
Part of Lungs & breathing clinical trials.
This trial tests whether transplanting a patient's own lung stem cells can improve lung function in people with chronic obstructive pulmonary disease (COPD). It aims to see if this treatment is safe and helps repair damaged lung tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD based on the 2021 GOLD criteria.
- Your lung function test shows a specific ratio (FEV1/FVC) below 70% after using a bronchodilator.
- Your ability to transfer carbon monoxide in your lungs (DLCO) is between 20% and 80% of what is expected for someone your age and size.
- You are not pregnant, breastfeeding, or planning pregnancy within the next year (for men, not planning for your partner to become pregnant).
- You do not have active syphilis, HIV, hepatitis B, or hepatitis C.
- You have no current or past history of cancer (except certain skin cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding umbilical cord stem cells to standard triple therapy can help people with Group E COPD. It aims to see if this approach improves lung function and quality of life.
This trial tests a new stem cell therapy for people with moderate to severe COPD who have not improved with standard treatments. The goal is to see if the therapy is safe and can help improve lung function.
This trial is testing a new type of cell therapy called REGEND007 for people with COPD. It looks at whether the treatment can help improve how far you can walk and your overall breathing.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This trial tests whether transplanting your own lung stem cells can repair damaged airways caused by bronchiectasis. It is for people with moderate to severe breathing impairment and aims to improve lung function.
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.